Cero Therapeutics Holdings CERO Cash Flow Statement (2021-2026)

OTC CERO
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Cero Therapeutics Holdings Quarterly Cash Flow Statement

Periods 19 quarters
Latest Jun 2026

Cero Therapeutics Holdings reported cash from operations of -$7.90M and free cash flow of -$7.90M for the quarter ended Jun 2026, down 70.9% year over year. This cash flow statement covers 19 quarters of results from Dec 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -0.38M-0.11M0.08M-0.26M-2.44M-2.09M-1.35M-1.27M-1.73M-2.45M-4.23M0.67M-5.11M-5.42M-4.86M-4.54M-5.89M-1.03M
Depreciation and DepletionDep. & Depletion 0.12M0.12M0.12M0.11M0.08M0.11M0.11M0.10M0.08M0.08M0.07M0.07M0.06M0.06M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges 0.14M0.61M
Depreciation & Amortization (CF)Dep. & Amort. 0.12M0.12M0.12M0.11M0.08M0.11M0.11M0.10M0.08M0.08M0.07M0.07M0.06M0.06M
Share-based CompensationStock Comp. 0.03M1.40M0.02M0.02M0.09M0.03M0.40M-0.98M0.30M0.71M0.35M0.26M1.62M1.12M
Gains from Investment SecuritiesGains Investment 0.03M0.23M0.66M-0.92M-0.90M-3.10M
Other non-cash itemsOther Non-Cash 0.16M0.16M0.17M0.17M0.06M0.18M0.18M0.19M0.16M0.24M0.50M-1.11M0.21M0.22M
Change in Working Capital
Change in Account PayablesChange Payables 0.11M0.04M0.55M0.48M0.21M0.21M0.39M-0.41M-0.26M0.32M0.49M0.73M-0.17M0.86M0.50M0.11M0.53M
Change in Accured ExpensesChange Accured Exp. 0.11M0.04M0.55M0.94M0.36M1.13M0.17M0.22M0.14M0.85M0.54M0.82M-0.30M-0.10M-0.02M0.02M0.14M-0.02M
Change in TaxesChange Taxes 0.54M-0.04M-0.01M
Change in Other Operating AssetsOther Assets Change -0.02M-0.08M-0.08M-0.07M0.00M-0.11M-0.09M0.01M0.67M-0.26M-0.26M-0.06M0.29M-0.12M0.09M0.54M-0.35M-0.11M
Change in Other Operating LiabilitiesOther Liabilities Change -0.16M-0.16M-0.17M-0.18M-0.06M-0.27M-0.19M-0.13M-0.21M-0.21M-0.22M-0.23M-0.24M-0.57M
Other Working Capital ChangesOther WC Changes 0.02M0.08M0.08M0.07M-0.15M-0.05M-0.08M-0.18M-0.73M-0.01M0.07M-0.07M-0.50M-0.09M-0.31M-0.77M0.12M-0.46M
Cash from OperationsCash from Ops. -0.31M-0.24M-0.17M-0.37M-0.20M-0.88M-0.26M-0.19M-4.44M-3.54M-2.76M-1.54M-4.45M-4.62M-3.21M-3.83M2.80M-7.90M
Investing Activities
Purchase of InvestmentsInvestments Purchased 0.10M0.28M0.07M13.89M
Sale and Maturity of InvestmentsInvestments Sold 181.04M5.76M0.07M
Cash from Investing ActivitiesCash from Investing 180.71M-0.10M0.29M5.69M-13.82M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 0.22M0.16M4.100.12M
Long-Term Debt RepaymentsLT Debt Repayment 1.00-1.000.02M
Non-Current Debt 0.22M0.16M-0.02M4.100.12M
Short-Term Debt issuancesST Debt Issuance 0.41M1.50M2.16M
Short-Term Debt repaymentsST Debt Repayment 0.15M0.10M
Current Debt 0.41M-0.15M-0.10M1.50M2.16M
Net Debt Issuances and RepaymentsNet Debt Issuance 0.22M0.16M0.39M-0.15M-0.10M0.12M1.50M2.16M
Change in Capital Stock
Common Stock IssuedStock Issued 0.01M600.00-1.001.90M4.06M1.23M-0.64M1.28M1.45M0.46M0.50M
Shares Repurchased 27.84M
Net Shares Issued and RepurchasedNet Shares Issued 0.01M600.00-27.84M1.90M4.06M1.23M-0.64M1.28M1.45M0.46M0.50M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued 6.76M0.00M-5.82M0.50M
Net Equity Issued and RepurchasedNet Equity Issued 0.01M600.00-27.84M6.76M0.00M1.90M-1.76M1.73M-0.64M1.28M1.45M0.46M0.50M
Other financing activitiesOther financing 0.01M-0.40M
Cash from Financing ActivitiesCash from Financing 0.01M0.52M-5.42M-27.68M7.16M2.59M2.49M1.49M6.32M2.72M1.42M3.45M1.96M2.41M
Additional items
Change in Cash -0.31M-0.24M-0.05M41.63M-0.30M-0.07M0.01M-41.69M2.72M-0.95M-0.27M-0.05M1.88M-1.90M-1.28M-0.36M-0.80M0.08M
Ending Cash Balance 1.10M0.79M0.55M0.51M42.14M0.18M0.11M0.12M0.10M4.59M3.65M3.30M3.33M5.10M3.30M1.90M1.66M0.86M0.94M
Free Cash FlowFCF -0.31M-0.24M-0.17M-0.37M-0.20M-0.88M-0.26M-0.19M-4.44M-3.54M-2.76M-1.54M-4.45M-4.62M-3.21M-3.83M2.80M-7.90M
Net Cash FlowNCF -0.31M-0.24M-0.17M180.34M-0.29M-0.08M0.01M-41.69M2.72M-0.95M-0.27M-0.05M1.88M-1.90M-1.78M-0.38M4.76M-5.49M
Income Taxes PaidTaxes Paid 0.09M

Cero Therapeutics Holdings Cash Flow Statement API

Pull Cero Therapeutics Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CERO&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY